chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the injection and within minutes I felt lightheaded and like I was going to pass out. I immediately laid down on the floor in the middle of the pharmacy. After that everything went black. When I woke up, I was told I had a seizure. By standards said I was having full body convulsions for around 30 seconds. EMS was called to the scene. My vitals were taken, along with an EKG. Paramedics suggested I be taken to the hospital. I refused to go. When I contacted the pharmacy about getting the second injection, the pharmacist advised I do not get the second dose due to the adverse reaction I had during the first one.
Left arm (flu vaccine site in deltoid region): Sharp pain during injection. Dull pain at site immediately after injection. Starting three or four hours after injection and continuing for two days, left deltoid too painful to lift arm to side. On third day, pain began to ease, but remained and affected ability to get dressed, sleep comfortably, reach up into cupboard, etc.   Started naproxen at 440 mg 2X daily on 10/31/2021. That does not seem to make a difference.  Pain has continued for four weeks now, slowly improving. Most problematic at night in bed, particularly when lying on back.  nb, At no time has there been swelling or redness at injection site (or elsewhere). Also, the COVID booster site never presented any problem.
Minutes after the shot I felt like I had taste of metal under my tongue, it progressed and my whole mouth taste like metal as of the time of this report.
Pt reported itching all over the body about 5-10mins after the vaccine. I gave her 25mg of Diphenhydramine solution by mouth immediately and asked her to monitor the symptoms and let us know. She mentioned she has Lupus and is not on any drugs for it right now. Other pharmacist called her Dr and the patient herself called Dr to report the reaction. Dr sent a prescription for Prednisone 10mg and she took 2 tabs right away.
Since the vaccine, I have had intermittent tingling of the tips of my fingers. It is all day, including during the night but it comes and goes. Both hands have the tingling finger tips.
The vials were kept in frozen state. The freezer got warmer for about 8 minutes (6:08 to 6:16 PM on 16Aug2021)reaching max temperature of (+) 6.3 degrees Fahrenheit.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vials were kept in frozen state. The freezer got warmer for about 8 minutes (6:08 to 6:16 PM on 16Aug2021)reaching max temperature of (+) 6.3 degrees Fahrenheit.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vials were kept in frozen state. The freezer got warmer for about 8 minutes (6:08 to 6:16 PM on 16Aug2021)reaching max temperature of (+) 6.3 degrees Fahrenheit.). At the time of the report, PRODUCT STORAGE ERROR (The vials were kept in frozen state. The freezer got warmer for about 8 minutes (6:08 to 6:16 PM on 16Aug2021)reaching max temperature of (+) 6.3 degrees Fahrenheit.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment medications were reported.  The excursion occurred on 16Aug2021. The vials did not previously experienced excursions. Out of those 250 doses affected, 70 doses have been administered. Lot # are 005C21A and 048C21A.   Reporter did not allow further contact
Tdap was given to R deltoid Medquadfi was given second. After Menquadfi, patient stated "Ah, that like stings" I watched patient and talked with him and his mother for 90 seconds. He was standing independently. Patient and his mother were dismissed. I proceeded out of the room. Mother stated "Help me! Help me!" when I entered the room, patient was laying prone with his chin facing right shoulder. Patient was unresponsive for approximately 10-15 seconds. His pulse was regular and strong. Ice was applied to the back of his
On day 10 after the first Moderna injection, injection site became swollen, red, and itchy. It was around 3x2.5 inches across and hot and painful to the touch. Today is day 12 and the injection site still looks the same.
4:45PM: Patient complained of nausea. Sip of water given. Patient states that it is her nerves. Pretzels and sprite given for snack. BP checked 132/103 HR-94 4:50PM BP 128/91 HR-101 No acute distress noted 5:00PM BP 125/88 HR 101 Patient resting on couch 5:13PM BP 123/83 HR 100 No acute distress 5:15PM Escorted to car with no problems noted.
Lymph nodes on her clavicle and armpit; joint pain; Hard lump on her arm; red ring; Metallic taste; Flu aches in her neck and shoulder region.; Wet sensation on her arm and warm feeling; A spontaneous report was received from a health care professional, who is a 42-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced metallic taste, wet sensation on her arm, warmth feeling, flu aches in neck and shoulder region, red ring and hard lump on her arm (that was itchy and sore), joint pain and lymph nodes on her clavicle and armpit (which was warm, red and swollen)   The patient's medical history was not provided. No concomitant medications were reported.  On 08 JAN 2021, the patient received their first dose of mRNA-1273 (Batch number: 011J20A) intramuscularly in her left arm for the prophylaxis of COVID-19 infection.  On 08 JAN 2021, the patient received her first dose at 9:45 am. Immediately after the vaccine the patient experienced metallic taste which disappeared after 5 minutes. The patient stated that after 2 hours she felt wet sensation on her arm, warmth feeling that was resolved. After 6 hours she had flu aches in neck and shoulder region. On 9 JAN 2021, she noticed red ring and hard lump on her arm (which was itchy and sore). On 13 JAN 2021, she experienced joint pain. The patient also reported that she had lymph nodes on her clavicle and armpits (which was warm, red and swollen).  Treatment included was ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, metallic taste, wet sensation on her arm, warmth feeling, flu aches in neck and shoulder region, were resolved on 09JAN 2021 and red ring and hard lump on her arm (that was itchy and sore), were resolved on 12 JAN 2021 and joint pain was considered resolved on 13 JAN 2021. Lymph nodes on her clavicle and armpit (which was warm, red and swollen), were considered not resolved.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Recieved the vaccine 12/21 and on the evening of 12/22 my arm became very sore, more than usual for other shots such as the flu shot I received in October this year. It kept me awake it hurts at the injection site down to my middle finger and up my neck. No redness or swelling that I could see. No fever that I can tell.
Date and time adverse event started: ongoing for one year    Did the adverse event start after the first or second vaccination?  ongoing but feels vaccine may have contributed to symptoms, 1 st vaccination Recommended to see provider patient retuned our f/u call wt loss 30 # over 2 yrs related to anxiety and depressin vaccine not cause of sx
Not as sharp; feeling tired; wobbly; This is a spontaneous report based on the information received by Pfizer from Genentech. A contactable consumer (patient) reported that a 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included endometriosis (not ongoing), blocked fallopian tubes (not ongoing), hot flashes (not ongoing), sinus polyps (not ongoing), ongoing assistive device use, ongoing hypothyroidism, ongoing sinus infections, ongoing asthma, ongoing sleep apnea. Concomitant medications were not reported. On unknown date, the patient experienced feeling tired, wobbly, and not as sharp. Outcome of the events was unknown.   No follow up attempts are possible. No further information is expected.
This report from claims services (initial receipt 23-FEB-2011) concerns a 14 year old female patient who visited her physician's office for evaluation of an unspecified illness on 21-FEB-2011. On 21-FEB-2011, the patient received AFLURIA and PNEUMOVAX. Within minutes, the patient's face became purple and she had difficulty breathing. The patient has had a flu vaccines in the past but the reporter believed that this was the patient's first dose of PNEUMOVAX. The event outcome was unknown. Case correction (26-Mar-2012): case upgraded to serious.
This spontaneous report was received from a Certified medical assistant and refers to an unspecified number of patients of unknown age and gender. Medical history and concomitant medications were unknown. It was reported that improperly stored doses of PEDVAXHIB Lot # K016965, expiry date 20-JUL-2017, (dose and route were not reported), were given to unspecified patients on unspecified dates, between 22-JUL-2015 and 31-DEC-2015. No adverse effects were reported. No product quality complaint (PQC) was involved. It was also reported that GARDASIL 9 and PNEUMOVAX 23 were included on the lost of questionable temperature stability vaccines, but no doses were administered. This is one of three reports received from the same source. Additional information has been requested.
Site pain and itching the 1st 48hrs. Headache, nausea,vomiting, site pain,swelling,redness,itching after day 6. No medications used.025J20A
Janssen SARS-Covid-2 Vaccine Chills, fever, severe pain in left arm  from shoulder to hand, body ache, headache, flu like symptoms.
bilateral pneumonia; Initial information received on 24-Dec-2022 regarding an unsolicited valid social media serious case received from a consumer/non-healthcare professional (hcp).  This case involves Adult and unknown gender patient who experienced bilateral pneumonia after receiving vaccines INFLUENZA VACCINE and COVID-19 VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dose: unknown) (lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation) and had all the COVID-19 VACCINE boosters not produced (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) in unknown administration site for COVID-19 vaccination (COVID-19 immunisation).  On an unknown date, the patient developed a serious event of bilateral pneumonia (pneumonia) (unknown latency) following the administration of INFLUENZA VACCINE and COVID-19 VACCINE. This event was assessed as medically significant. The patient was hospitalized for this event.  It was reported, patient just home from hospital after 6 days. It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) and COVID-19 VACCINE (COVID-19 VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (bilateral pneumonia).  At time of reporting, the outcome was Recovering / Resolving for the event bilateral pneumonia.; Sender's Comments: company comment dated 28-Dec-2022: This case involves an Adult and unknown gender patient who experienced bilateral pneumonia after receiving vaccines INFLUENZA VACCINE and COVID-19 VACCINE. Based upon the reported information, the role of vaccine cannot be assessed. Additional information regarding additional risk factor, medical treatment, concomitant medications and lab investigations, underlying medical history excluding other predisposing etiologies would be needed for complete assessment of the case.
pt brought to the ED and found to be positive for COVID; COVID PNA; worsening O2 saturations and new/worsening infiltrates on the CXR; placed on Vapotherm; admitted to ICU; given ABX; O2 saturations worsened even more requiring intubation; pt's condition deteriorated and family transitioned her to comfort measures; extubated and placed under hospice care; she passed away in the hospital
Pt called 6/2/06 stating had fever (slight) and felt "weird". Denied other problems. Instructed to continue Tylenol every 4-6 hrs as fever is not uncommon. Pt called again 6/5/06 stating that on 6/3/06, she woke up and R arm and side were numb. Went to urgent care that morning. Urgent care said reaction unrelated to vaccine and follow-up with private MD if symptoms continue.
This spontaneous report as received from a registered nurse refers to a 15 month old patient of unknown gender. The patient's concurrent conditions, medical history and drug allergies were not reported. On 28-OCT-2016, the patient was vaccinated with improperly stored PEDVAXHIB (dose and route not reported) from lot # M025194, expiry date: 22-MAR-2019, for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous temperature excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1610USA014705: US-009507513-1610USA014706.
6 weeks after getting his second COVID vaccine, my son experienced a burning sensation in the chest describing it a really hot and couldnt move. Then he very briefly blacked out for a few seconds. He had drank a soda and was saying "this doesnt taste right" (shortly before the event) then slowly passed out and couldnt move. Immediately afterward he seemed ok and said he felt he could breathe better when he came to. The following morning he went to the hospital and they said he had experienced a heart "arrhythmia" and had mild low potassium level. They gave him a potassium pill and sent him home. I just couldnt help but wonder if this was related to the vaccine and cannot be sure so I thought I should report it just in case. It was so out of nowhere.  I read on the website that there can be a rare heart event in boys 17-24.
Urticaria, no wheezing, facial swelling or sob.  Resolved with Benadryl .
Starting with my third anthrax shot I started feeling like I had ants crawling all over my face, just my face, and that there was a solid block in my chest
Child jerked arm during administration of vaccine. Redness was noticed post injection with small wheal located in the center of site.
This event was a vaccine error.  No known adverse event has been reported by the patient at this point in time.
Patient with 3 COVID vaccines who admitted with cough and dyspnea.  Provider d/c note:  "Acute respiratory insufficiency on chronic respiratory failure- etiology behind acute worsening likely multifactorial including COVID, HFpEF with infiltrates on x-ray and elevated BNP, chronic obstructive pulmonary disease.  Suspect COVID with some element of CHF. - patient has been weaned to his home 2 L of supplemental oxygen -he will continue on dexamethasone at home for COVID   COVID- patient received remdesivir therapy and will continue on steroids at home.  He was offered the full course of remdesivir but instead preferred to go home.  Risks and benefits discussed.  Bilateral venous stasis ulcers with concern for bilateral cellulitis on imaging- Has PVD. - patient was treated with vancomycin and Zosyn, and will complete a course of antibiotics at home. -wound care consulted, home care has been arranged for further wound care and he will seen the wound care clinic team"
Urticaria seconds after vaccines given. Started on L leg extending to Abd (Very mild). Benadryl 12.5 1/2 tsp given & rash resolved after 45min period.
No PQC or additional AEs reported; 31 year old male patient received GARD ASIL 9 on following dates. # 5/27/2020 #2 7/17/2020 #3 10/6/2020. Dosing schedule not followed as in PI; This spontaneous report was received from an unspecified reporter referring to a 31-year-old male patient. Information about medical history, concurrent conditions and concomitant therapies was not provided.      On 27-MAY-2020, 17-JUL-2020 and 06-OCT-2020, the patient was vaccinated with three doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (inappropriate schedule of product administration). One dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was reported as 0.5 ml, lot # 1659422, expiration date 04-SEP-2022.  No adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1659422; expirationdate: 04-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
pt recv vax & had a violent reaction of nausea, vomiting, diarrhea, etc that lasted approx 1wk;
pt recv vax 1996 & pt devel a very mild chickenpox rash;
Patient received a 10 days expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 44-year-old female patient who received HBV (Engerix B) (batch number KQO79, expiry date 12th August 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 22nd August 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 22nd August 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-AUG-2022 Reporter's Comment: The reporter reported that, a patient received a 10 days expired dose of Engerix-B. The reporter consented to follow up. Additional Supportive Information: The patient received expired dose of Engerix-B, which led to expired vaccine used.
The next day I had vertigo. I did not get treated. It went away on its own after about a week.
Patient underwent both colonoscopy with polypectomy and received flu shot in the same week, then on the date above developed progressive pelvic and pectoral weakness to the point of requiring hospitalization, there the house rheumatologist Dx him with PMR despite ESR of 38, no prior h/o of sxs and temporal h/o of both of the above intervention. This dx was confirmed by outside rheumatologist. Patient currently slowly improving on repeated steroid tapers.
Pt recvd vax 27APR92 & mom states that pt was very pale late that evening 27APR92 episode of screaming out-became stiff; pt seen by MD for cerebral irritability & deafness; pt is to receive no more Pertussis;
Platelet count dropped from 216  2 weeks before vaccine down to 166 on 3/10, down to 121 on 3/17, to 99 on 3/22, to 68 on 3/25, to 52 on 3/29. Given Dexamethasone  18mg on 3/26 then 20mg on 3/30 thru 4/2 .. as of 4/14 Platelets up to 188
Dizziness; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Dizziness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Dizziness). On 11-Feb-2021, DIZZINESS (Dizziness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    Reporter did not allow further contact
red rash; warm to touch; A spontaneous report was received from a reporter, concerning a female patient of 78-Years - age, who received Moderna's COVID-19 vaccine and experienced red rash, warm to touch.  The patient's medical history was not provided. No relevant  Concomitant product medication was provided by reporter.  On12 -feb-2021 , prior to onset of event  patient  received their first of two planned doses of mRNA-1273 (lot number 015M20A) via intramuscular for COVID-19 infection prophylaxis.    On 22-Feb-2021,the patient experienced red rash, warm to touch . Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events considered  was unknown at the time of this report.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1898089, expiry: 04-AUG-2021) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
This spontaneous report was received from a physician and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (strength, dose, route of administration, anatomical location, lot # and expiration date were not provided). On an unknown date, during a presentation to a group of physicians, the patient was diagnosed with serum sickness after administration of PNEUMOVAX 23 (onset date was not provided). The outcome of the event was not reported. The relatedness between the event and PNEUMOVAX 23 was not reported. This is one of two reports received from the same reporter. Additional information is not expected as the physician did not want to be contacted.
Approximately 2 to 3 weeks after receiving my COVID-19 Pfizer I began having joint pain in my shoulders, elbows, knees, digits, toe joints. I experiences muscle pain in my quads, biceps, calf area and upper back muscles. I have visited my primary care doctor and she has referred my to the rheumatologist for further evaluation on 3/9/2022.
One week after vaccination she woke with very enlarged, tender lymph node in the axilla of the same arm she received the vaccine. she also developed fatigue at the same time the lymph node was noticed. There was not fever or local redness or warmth. Size and tenderness of nodes has gradually improved although fatigue is unchanged. She was examined it was 4 days after the onset of symptoms.  At that time there were 3 enlarged lymph nodes in anterior aspect of right axilla ranging 1/2 - 1 cm in size.  Firm but not fixed. Mildly tender w/o warmth or redness.  No pectoral, epitrochlear or supraclavicular adenopathy.  No rashes or wounds on chest or upper extremity, No fever. Breast exam normal.